Time-course of clinical symptoms in young people at ultra-high risk for transition to psychosis by Meneghelli, A. et al.
OR I G I N A L A R T I C L E
Time-course of clinical symptoms in young people at ultra-high
risk for transition to psychosis
Anna Meneghelli1 | Angelo Cocchi1 | Maria Meliante1 | Simona Barbera1 |
Lara Malvini1 | Emiliano Monzani2 | Antonio Preti1 | Mauro Percudani1
1Programma2000 – Center for Early Detection
and Intervention in Psychosis, Department of
Mental Health and Addiction Services,
Niguarda Hospital, Milan, Italy
2Department of Mental Health & Drug Abuse,
ASST Bergamo Ovest – Treviglio, Niguarda
Hospital, BG, Italy
Correspondence
Antonio Preti, Department of Neuroscience
“Rita Levi Montalcini”, University of Turin, via
Cherasco 15, 10126, Turin, Italy,
Email: antonio.preti@unito.it; apreti@tin.it
Abstract
Background: Ultra-high risk (UHR) people are a heterogeneous group with variable
outcomes. This study aimed at (a) estimating trajectories of response to treatment to
identify homogeneous subgroups; (b) establishing the impact on these trajectories of
known predictors of outcome in UHR subjects.
Methods: Mixed models of growth curves and latent class growth analysis (LCGA)
were applied to the 24-item brief psychiatric rating scale (BPRS) to measure the
response to treatment over 2 years in 125 UHR participants. Group differences were
tested on sociodemographic variables and clinical indicators that are known to affect
the outcome in UHR people.
Results: BPRS scores decreased across all tested models, with a greater decrease for
affective and positive symptoms than for all other dimensions of BPRS. Past admis-
sions to the hospital for psychiatric reasons other than psychosis and the presence of
a decline in premorbid functioning before the episode were associated with a slower
decrease of BPRS score. LCGA identified three classes, one (82% of participants) with
a progressive decrease in the BPRS scores, a second class with a moderate improve-
ment (10%), and a third with no improvement (8%). Those in the ‘no improvement’
class had a higher chance of receiving a diagnosis of psychosis within the spectrum
of schizophrenia.
Conclusion: Most UHR individuals that are treated within a specialized service
undergo substantial improvement in their psychopathology, but some seem resistant
to the protocol of treatment and need close reevaluation within the first 12 months
of treatment.
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1 | INTRODUCTION
Within the framework of a transdiagnostic clinical staging model
(Shah et al., 2020), increasing attention has been devoted to people
showing signs of incipient psychosis, so-called individuals with ‘ultra-
high risk’ (UHR) for psychosis (Parabiaghi et al., 2019; Yung
et al., 2004; Yung & McGorry, 1996). In so far, the transition to psy-
chosis has been the most investigated outcome for UHR samples,
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with estimates ranging between 18% and 30% depending on follow-
up and sample (Fusar-Poli et al., 2016; Nelson et al., 2011). However,
UHR people are a heterogeneous group (Zhang et al., 2020), with sig-
nificant comorbid disorders (Albert et al., 2018) that may impact on
the course of illness. The exclusive focus on the transition to psycho-
sis may obscure different pathway to remission and recovery in this
population (Lin et al., 2015; Simon et al., 2013). Some recent studies
attempted to identify separate pathways to symptoms change in UHR
samples.
Polari et al. (2018) applied a complex system of stratification of
symptoms to a UHR cohort that included 202 individuals, over a
12-month follow-up, and identified six trajectories: recovery (35.7%),
remission (7.5%), any recurrence (20%), no remission (17.3%), relapse
(4.0%) and transition to psychosis (15.8%). Long duration of untreated
illness (DUI) and high depression scores were related to the most
unfavourable outcomes in this cohort. By applying a more transparent,
data-driven approach based on latent class growth analysis (LCGA) to
a larger sample of the same cohort including 304 individuals followed
up for an average of 40 months, Hartmann et al., (2020) found two
classes with trajectories with mostly parallel slopes (i.e., improving
symptoms/functioning over time), which were differentiated mainly
by the severity of symptoms and functioning at baseline. In this study,
female gender, older age, substance use and lower cognitive function-
ing were related to the class with the worst outcome. Allswede
et al. (2020) applied group-based multitrajectory modelling, a form of
LCGA, to the cohort of the North American Prodrome Longitudinal
Study [NAPLS-2], including 422 individuals that met criteria for a clini-
cal high-risk (CHR) syndrome per the Structured Interview for Prodro-
mal Risk Syndromes (SIPS; Miller et al., 2003). They found three
classes: one of substantial improvement across all investigated
domains (30% of the sample), one with moderate impairments across
domains and some positive outcome at follow-up (49%), and one with
severe impairments across domains and no positive outcome at
follow-up (22%). Similar patterns of change (i.e., rapid, moderate, or
no improvement) were replicated in an independent sample of
133 CHR individuals of the first phase of the NAPLS (NAPLS-1).
In past studies, LCGA has been used to identify trajectories
towards symptoms remission. The main advantage of LCGA is that it
is data-driven, thus allowing the identification of subgroups without
the application of superimposed artificial cut-off points. LCGA also
consents to the exploration of the factors that impact class member-
ship. So far, only one study examined the impact of some known pre-
dictors of poor outcome in UHR individuals.
1.1 | Aims
In this study, we applied mixed models of growth curves and LCGA to
investigate the response to treatment over 2 years in a sample of
UHR patients that were enrolled within an early intervention service.
The conditional growth model tends to assume a linear growth trajec-
tory, while the latent class growth mixture model assumes a non-
linear growth. The first model assesses whether a change over time
has occurred in the sample and consent to evaluate whether some
known predictors influence this change. The second model will allow
the identification of subgroups that change in a different way across
time, either linearly and non-linearly. In particular, we wanted
(a) estimating trajectories of response to treatment to identify homo-
geneous subgroups; (b) establishing the impact on these trajectories
of known predictors of outcome in UHR subjects.
2 | METHODS
Data were collected during the routine assessment of the patients
participating in the Programma2000, an early intervention service of
the Niguarda Hospital of Milan (Cocchi et al., 2008). The study com-
plies with the 1995 Declaration of Helsinki and its revisions (World
Medical Association, 2013). Written informed consent was acquired
from each participant. The time interval of the study is from 1999 to
2015, when the Programma2000 was reorganized in both the proce-
dures of assessment and the program of cure.
2.1 | Participants
Programma2000 is a multi-modal, community-based outpatient clinic
with a served catchment area that includes 200 000 inhabitants.
Inclusion criteria for the UHR diagnosis were: help-seeking status for
distress related to psychosis; aged 17 to 30 years old; to comply with
the Personal Assessment and Crisis Evaluation (PACE) Clinic in Mel-
bourne criteria for UHR (Yung et al., 2004; Yung & McGorry, 1996);
to have had never received antipsychotic treatment before enrolment;
to have had never received a past or present diagnosis of schizophre-
nia, bipolar disorder or unipolar disorder with psychotic features. Peo-
ple with comorbid medical or neurological disorders or with substance
use disorders were excluded and referred to other specialized centres.
Recreational substance use not associated with substance use disor-
der was deemed eligible for treatment and inclusion in the study.
Each patient received a tailored, 3-years intervention package
based on pharmacotherapy, cognitive-behavioural psychotherapy,
psycho-education, group activities and skills training, family support.
Details of this treatment package were reported elsewhere (Cocchi
et al., 2008; Meneghelli et al., 2010).
2.2 | Measures
To assess response to treatment we used the 24-item brief psychiatric
rating scale (BPRS; Overall & Gorham, 1962; Roncone et al., 1999).
The BRPS has a Likert scoring in which the listed symptoms were
rated from 1 (absent) to 7 (extremely severe). BPRS total scores
ranges from 24 to 168, across a gradient of higher levels of psychopa-
thology. The total score of the BPRS is an accepted measure of out-
come in clinical trials (Leucht et al., 2007). A judgement of ‘much
improved’ rating on the Clinical Global Impression has been equated
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to a reduction of 58% in the BPRS total score at 1 month (Leucht
et al., 2005). We also assessed change over time across the main
dimensions of the 24-item BPRS, as defined by the most reproducible
factor structure of this version of the scale (Dazzi et al., 2016). Four
invariant subscales are described: Affect (including items on anxiety,
guilt, depression, suicidality), Positive Symptoms (hallucinations,
unusual thought content, suspiciousness, grandiosity), Negative Symp-
toms (blunted affect, emotional withdrawal, motor retardation) and
Activation (excitement, motor hyperactivity, elevated mood, distracti-
bility) (Dazzi et al., 2016). Details on the changes over time of the
scores of these four dimensions of the BPRS are reported in
the appendix.
From initial assessment (baseline), the BPRS was administered
every 6 months, to assess change over time in levels of psychopathol-
ogy. Inter-rater agreement was measured as intra-class correlation
coefficients (ICC), and median values for BPRS, calculated with a two-
way mixed-effects model, were .78 (95%CI: .71 to .84) in the current
sample; these values indicate moderate to good reliability according
to current guidelines (Koo & Li, 2016).
Sociodemographic (gender, age at first contact) and clinical indica-
tors that are known to impact outcomes in UHR samples were derived
from a detailed interview with the patient and a key informant, usually
a parent (see Table 1 for the list of indicators). Details on this proce-
dure were reported elsewhere (Cocchi et al., 2014). In the analysis,
continuous variables (age and DUI) were dichotomized to favour com-
parison with the other categorical variables. Although caution is
advised in interpreting the effects of dichotomization of continuous
variables (Chen et al., 2007), the statistical analysis is made simpler,
leading to an easier presentation of the results.
Conversion to psychosis in the sample was based on the formal
DSM-IV or DSM-IV-TR diagnosis of schizophrenia-spectrum psycho-
sis made by the therapists at the end of the three-year program.
2.3 | Statistics
Analyses were carried out with the Statistical Package for Social Sci-
ences (SPSS) version 20 and with dedicated packages running in R
(R Core Team, 2018). All tests were two-tailed (alpha set at p < .05).
Means with standard deviations or counts and percentages were
reported depending on the type of variable (continuous or nominal).
Comparisons between groups were by Student's t test, ANOVA or
Chi-square (with Yates correction when necessary). When n < 5 in
some group, we applied Fisher's exact test or the Freeman–Halton
extension of Fisher's exact test for contingency tables that are larger
than 2  2 (Freeman & Halton, 1951). The difference between the
score at baseline (minus the minimum score of 24, as in Leucht, 2014)
and the score at the end of the 2 years interval of the study (again,
minus the minimum score of 24) was calculated to measure improve-
ment on the BPRS across time.
Data were missing for an average of 5% in each time point, with
scarce overlap from a point to the other. Overall, less than 20% of
data were missing in the sample. We applied multiple imputations by
chained equations (mice) method (‘mice’ package version 3.13.0 run-
ning in R), to correct for missingness (van Buuren & Groothuis-
Oudshoorn, 2011). We used 20 imputed data sets. Rubin's method
was used to derive pool averaging across all imputed data sets.
Changes over time in the variable of interest (BPRS total score)
were assessed with a conditional growth model (Rubin, 1996). The
model was implemented with the ‘nlme’ package running in R
(Pinheiro et al., 2016). The ‘lme’ function was used to implement the
models. The impact of sociodemographic variables and some clinical
indicators on the response to treatment as measured by the BPRS
was also tested. Model fit was investigated according to Nakagawa




Age (years old) 22 (3); range: 16–30
16 to 20 years old 53 (42%)
21 years old or older 72 (59%)
DUI (months) 30 (22); range: 1–60
Less than 12 months 35 (28%)
1 years or more 70 (56%)
The DUI could not be determined 20 (16%)




History of substance use
Yes 22 (18%)
No 85 (68%)
Not enough information 18 (14%)
Family history of psychiatric disorders
Yes 67 (54%)
No 40 (32%)
Not enough information 18 (14%)
Decline in premorbid functioning
Yes 67 (54%)
No 40 (32%)
Not enough information 18 (14%)




Baseline 44 (12); range: 19–99
At 6 months 37 (9); range: 21–76
At 12 months 35 (8); range: 24–76
At 18 months 33 (8); range: 24–62
At 24 months 32 (7); range: 24–59
Note: All data are reported as mean (SD); range, or counts (percentage).
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et al. (2017) with the ‘MuMIn’ package running in R (Barton, 2018).
The proportion of variance explained by both fixed (time and group
membership) and random factors (intercept and slope at participants'
level) was reported as conditional (pseudo)R2.
LCGA was used to identify separate trajectories of subgroups of
patients across time (Jung & Wickrama, 2008). A quadratic function
of time at the population level (fixed effects), and a linear function of
time at the individual level were used to model changes over time of the
BPRS scores. The LCGA models were implemented with the package
‘lcmm’ running in R (Proust-Lima et al., 2017). The ‘lcmm’ function was
used to implement the LCGA models. The best model was expected to
minimize the values of the information criteria and to maximize entropy,
a measure of the accuracy of participants' classification (0 to 1). The
following information criteria were used: the Akaike information
criterion (AIC; Akaike, 1987), the Bayesian information criterion (BIC;
Schwarz, 1978), the sample-size adjusted BIC (SABIC, Sclove, 1987).
Minimum acceptable entropy values were ≥ .80 (Ramaswamy
et al., 1993). In assigning participants to the latent classes, average proba-
bilities per class ≥90% at a minimum were accepted.
Logistic regression in relation to LCGA-extracted class member-
ship was used to evaluate their links with sociodemographic variables
and clinical indicators. Variance explained by the model (0% to 100%)
was assessed with the pseudo-R2 McFadden measure (Long, 1997).
Since events were rare in some of the classes, we also applied Fisher's
exact test to these calculations.
3 | RESULTS
The study included 125 UHR patients, mostly male participants. The
mean age in the sample was 22 years old, with no differences by gen-
der (males: 21.9 ± 3.5 vs. females: 22.2 ± 3.6; t = .69; df = 123;
p = .276). In the sample, 28% of the participants had a DUI less than
12 months (Table 1).
Participants were rarely admitted to the hospital for psychiatric rea-
sons (11%); 54% reported a family history of psychiatric disorders,
13 with non-affective psychosis among the relatives (20%), and 28 with
a relative that received the diagnosis of an affective disorder, either
major depressive disorder or bipolar disorder (42%). A minority reported
recreational substance use (18%). A decline in premorbid functioning was
reported in 54% of participants. Over time, the improvement in symp-
toms was substantial, with on average 60% decrease of the BPRS scores.
TABLE 2 Results of the conditional growth models
Variables in the model
Statistics
Beta SE df t p Log likelihood (LL) Conditional R2
Time 3.4 .4 498 7.4 <.0001 LL = -2172.4, 61.2%
Gender 1.4 2.4 123 .6 .56
Time x gender .8 .5 498 1.4 .13 p = .0082
Time 2.5 .4 498 6.9 <.0001 LL = -2174.4, 57.1%
Age 2.6 2.2 123 1.2 .22
Time x age .8 .5 498 1.7 .078 p = .0156
Time 3.7 .4 418 8.7 <.0001 LL = -1809.2, 58.2%
DUI .05 2.4 103 .02 .98
Time x DUI .5 .5 418 1.0 .30 p = .0066
Time 2.9 .3 498 1.8 <.0001 LL = -2172.7, 6.6%
Past admissions to hospital 8.3 3.4 123 2.4 .017
Time x past admissions 1.2 .8 498 1.5 .13 p = .0007
Time 3.3 .3 426 12.5 <.0001 LL = -2322.3, 57.8%
Recreational substance use 3.6 2.7 105 1.3 .19
Time x substance use .4 .6 426 .7 .47 p = .0177
Time 3.2 .4 426 7.6 <.0001 LL = -1849.3, 58.2%
Family history 1.4 2.4 105 .6 .54
Time x family history .2 .5 426 .4 .69 p = .0770
Time 2.2 .4 426 5.1 <.0001 LL = -1847.9, 58.3%
Premorbid functioning 4.7 2.4 105 1.9 .055
Time x premorbid functioning 1.4 .5 426 2.5 .011 p = .0019
Time 2.9 .3 498 9.8 <.0001 LL = -2176.4, 57.9%
Dropout 2.2 2.3 123 .9 .34
Time x dropout .6 .5 498 1.0 .29 p = .0472
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In the sample, 8 UHR patients received a formal diagnosis of
schizophrenia-spectrum psychosis at the end of the 3-year program.
3.1 | Impact on symptomatic improvement of
sociodemographic and clinical variables
The conditional growth model revealed a substantial decrease of the
scores on the BPRS across time, on average of three points every
6 months (Table 2).
A slower decline in BPRS was observed in those with past admis-
sions to the hospital for psychiatric reasons other than psychosis and
in those with decline in premorbid functioning before the episode.
Age, gender, a family history of psychiatric disorders, a history of rec-
reational substance use, and dropping out of treatment after the first
2 years did not influence the decrease of BPRS scores over time. The
fit of all models was good, with Conditional R2 above 50%. The effect
of the predictor on the explained variance was minimal, with most of
the variance attributable to the change over time of the scores on
the BPRS.
When the BPRS items were partitioned into four subgroups of
affective, positive, negative and activation symptoms, we found that
affective (one or more points reduction every 6-months, p < .0001)
and positive symptoms (.6 to 1 point reduction every 6-months,
p < .0001) were more prone to change than negative symptoms and
symptoms of psychomotor activation (.3 or less point reduction every
6-months, p < .05). Thus, changes in total BPRS scores could be attrib-
uted principally to changes in affective and positive symptoms.
3.2 | Trajectories of response to treatment
In the LCGA, the indicators of fit decreased from the 1-class model to
the 6-class model except for BIC, which increased after the 3-class
model (Table 3). Entropy in the 3-class model was acceptable (>80%),
but the probability of assignment to the class was suboptimal (it was
TABLE 3 Fit statistics for 1–6 class latent class growth mixture models
n. classes Log-likelihood AIC BIC SABIC Entropy Posterior probabilities above 90% in each class
1 2138.05 4290 4309 4287 – –
2 2123.01 4268 4299 4264 .91 73%
3 2098.95 4227 4270 4222 .85 61%
4 2091.98 4221 4275 4215 .87 74%
5 2075.90 4197 4262 4190 .87 88%
6 2070.00 4194 4270 4184 .88 89%
F IGURE 1 Treatment response trajectories over 2 years. On the left, raw data for all participants (each with their trajectory) and the
estimated three-classes trajectories (wider lines). On the right, the smoothed trajectories of the three classes with the confidence interval, which
is tighter in the larger class and larger in those with limited sample size
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above 90% in just 61% of cases). Both entropy and the maximal prob-
ability of assignment to the class increased in the 4-class, 5-class and
6-class models, but in these models, only three classes had
participants above 5%, the other retrieved classes had 1% or even less
assigned participants. Therefore, the 3-class model was chosen. Most
participants (n = 102) were assigned to class 1 (82%); class 2 totalled
TABLE 4 Baseline clinical variables across the 4 latent classes
Class 1* Class 2 Class 3
McFadden R2
N = 102 N = 13 N = 10
Gender 3.0%
Males 70 (69%) 12 (92%) 6 (60%)
Females 32 (31%) 1 (8%) 4 (40%)
OR (95% CI) 1 5.4 (.6–44.0) .7 (.2–2.6)
Fisher's exact test p = .105 p = .724
Age (years old) 2.6%
16 to 20 years old 42 (41%) 4 (31%) 7 (70%)
21 years old or older 60 (59%) 9 (69%) 3 (30%)
OR (95% CI) 1 .6 (.2–2.2) 3.3 (.8–13.6)
Fisher's exact test p = .558 p = .101
DUI (months) .4%
Less than 12 months 29 (33%) 3 (27%) 3 (43%)
1 years or more 58 (67%) 8 (73%) 4 (57%)
OR (95% CI) 1 .7 (.2–3.0) 1.5 (.3–7.1)
Fisher's exact test p = 1.00 p = .686
Past admissions to hospital for psychiatric reasons 3.5%
Yes 8 (8%) 3 (23%) 3 (30%)
No 94 (92%) 10 (77%) 7 (70%)
OR (95% CI) 1 3.5 (.8–15.4) 5.0 (1.1–23.3)*
Fisher's exact test p = .109 p = .058
History of recreational substance use .2%
Yes 19 (21%) 2 (17%) 1 (17%)
No 70 (79%) 10 (83%) 5 (83%)
OR (95% CI) 1 .7 (.1–3.6) .7 (.1–6.7)
Fisher's exact test p = 1.00 p = 1.00
Family history of psychiatric disorders 1.2%
Yes 54 (61%) 8 (67%) 5 (83%)
No 35 (39%) 4 (33%) 1 (17%)
OR (95% CI) 1 1.3 (.3–4.6) 3.2 (.3–28.9)
Fisher's exact test p = .762 p = .403
Decline in premorbid functioning 6.4%
Yes 54 (61%) 11 (92%) 2 (33%)
No 35 (39%) 1 (8%) 4 (67%)
OR (95% CI) 1 7.1 (.9–57.7) .3 (.05–1.8)
Fisher's exact test p = .051 p = .224
Dropout of treatment after 2 years 1.0 .3%
Yes 30 (29%) 5 (38%) 3 (30%)
No 72 (71%) 8 (62%) 7 (70%)
OR (95% CI) 1 1.5 (.4–4.9) 2.0 (.2–4.2)
Fisher's exact test p = .531 3.0 p = 1.00
Latent Class 1 was used as a reference term.
Note: Statistically significant results are in bold. * p<0.05.
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13 participants (10%); the remaining participants (n = 10) were
assigned to class 3 (8%). Those in class 1 showed a smoothed
decrease in BPRS scores starting from values that were, on average,
lower than the values observed in the other two classes (Figure 1).
BPRS scores at baseline were 40.9 ± 8.1 in class 1; 62.7 ± 12.8 in
class 2; 54.1 ± 11.5 in class 3: F(2;122) = 40.5; p < .0001; Tukey's
honestly significant difference: p < .0001 in the comparison between
class 1 and the other classes. Those in class 2 had a sharp decrease in
BPRS scores in the first 6 months of treatment and remained in remis-
sion in the following months. Those in class 3 did not improve rele-
vantly, although after 24 months of treatment they showed lower
BPRS scores than at baseline. Across classes, participants showed
some recurrence in symptoms, with worsening (hence, increase in
BPRS scores) at 12 or 18 months, with subsequent decrease.
Those in class 3 were more likely to have had a history of past
admissions to the hospital for psychiatric reasons. However, the
results of the Fisher's exact test did not confirm the association. No
other links were found with variables that have the potential to
impact the outcome in UHR patients (Table 4).
At the end of the 3-year program, those in class 3 were statisti-
cally more likely to have received a DSM-IV/DSM-IV-TR diagnosis of
schizophrenia-spectrum psychosis than those in the other two classes:
class 1, n = 2 (15.4%); class 2, n = 3 (2.9%); class 3, n = 3 (30%);
χ2 = 13.08; df = 2; p = .0014; Freeman–Halton extension of Fisher's
exact test: p = .0005.
4 | DISCUSSION
Most UHR individuals who access an early intervention service
undergo improvement and progressive change of their symptoms.
The peak improvement occurs after 12 months of treatment. How-
ever, a subgroup of those who improve may undergo cycles of
worsening and further improvement across time. UHR people that
have higher baseline scores of psychopathology have different
trajectories than those observed in the majority of those who
improve. A subgroup undergoes a rapid amelioration followed by a
smooth worsening of their symptoms. Another subgroup does not
improve relevantly over the first 2 years of treatment, and this
group has a greater risk of transition to psychosis. Most change in
symptoms was attributable to a decrease of affective and positive
symptoms. Other dimensions of the BPRS, such as negative symp-
toms, were less prone to changes.
Gender and age did not emerge as predictors of symptoms trajec-
tories as they were in the study of Hartmann et al., (2020), and this
may depend on a shorter range of age in our sample and a greater
prevalence of males than in the study of Hartmann et al., (2020). The
lack of impact of substance use is coherent with past investigation on
the topic (Farris et al., 2020; Hartmann et al., 2020). All other known
predictors of outcome in UHR samples were not related to the trajec-
tories that have been identified in this study, except a decline in
premorbid functioning before the episode, which was related to the
reduced improvement of psychopathology as measured by the BPRS.
The level of functioning was related to the trajectories of change that
were identified by LCGA in the study of Hartmann et al., (2020) but
not in the study of Allswede et al. (2020). However, the results of this
study are more similar to the findings of Allswede et al. (2020), who
identified three trajectories of change (rapid, moderate and no
improvement), than to those of Hartmann et al., (2020), who found
two trajectories with progressive and constant improvement. Hetero-
geneity of the samples may partially explain these differences, as well
as the different measures to which the LCGA was applied.
This study is not exempt from limitations, and albeit it was based on
state-of-the-art statistics it lacked a control group. This was the main lim-
itation of the study and depended on the lack of an agreement with the
psychiatric services operating in neighbour areas about the application of
an assessment detailed and repeated as the one that it is implemented in
the Programma2000. The sample size was too limited to detect specific
associations of the longitudinal classes with some of the predictors of
outcome that were investigated in the study. Moreover, the use of a
6-month interval for repeated assessment might have prevented a better
definition of the trajectories. The availability of only binary data (yes or
not) for some predictors might have limited the identification of relevant
relationships. Finally, because of sample size, we were unable to apply a
method to approximate the distribution of trajectories across time on
multiple variables as in the NAPLS-2 study (Allswede et al., 2020). Thus
we were unable to determine whether some specific dimension of symp-
toms (whether affective, positive, negative, or activation) contributed
most to the diversion of classes 2 and 3 from the pattern of class 1, which
was the majority in the sample.
5 | CONCLUSIONS
Most UHR individuals undergo substantial improvement when treated
within an early intervention service. However, some of these patients
seem resistant to the multimodal protocol of treatment that is adminis-
tered and probably need close reevaluation within the first 12 months of
treatment to identify factors that are related to scarce improvement.
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APPENDIX A.
Mean, SD and range of values for the four dimensions of the BPRS across time, from baseline assessment to 24 months. Data are reported in suc-
cession for Affective symptoms, positive symptoms, negative symptoms and activation
BPRS Time Affective symptoms Positive symptoms Negative symptoms Activation
Baseline 14 (4); range: 5–32 10 (4); range: 6–26 6 (3); range: 3–18 8 (3); range: 6–29
At 6 months 11 (4); range: 5–23 8 (2); range: 6–21 5 (3); range: 3–17 7 (2); range: 6–18
At 12 months 9 (3); range: 5–21 7 (2); range: 6–21 5 (3); range: 3–17 7 (2); range: 6–17
At 18 months 9 (3); range: 5–19 7 (2); range: 6–17 4 (2); range: 3–10 7 (2); range: 6–15
At 24 months 9 (3); range: 5–19 7 (2); range: 6–16 4 (2); range: 3–16 7 (2); range: 6–15
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